Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/3/2011

tain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTS All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and th
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
2. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
3. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
4. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
5. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
6. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
7. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
8. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
9. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
10. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
11. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)... Columbia and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") ... year-end financial statements.  The Company recently changed its fiscal ... an application to list its common stock on a ... DelMar,s financial statements as filed with the United ...
(Date:8/29/2014)... , Aug. 29, 2014 ... PHG AEX: PHIA) ... European Society of Cardiology (ESC) Congress ... highlighting the full range of its cardiology solutions serving clinicians ... from prevention and diagnosis, to ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... 26 A landmark study of 22 million ... a two-year period has confirmed the theory that ... protection against accidental needlestick injuries (NSIs) than early ... devices or those with manually sliding shields or ...
... Oct. 26 Native to the high Andes, Maca Root, ... effects, is providing effective relief for an increasing number of ... at the Center for Cardiovascular Sciences at Albany Medical College ... to mice could raise their tissue levels of IGF-1.  This ...
Cached Medicine Technology:Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 2Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 3Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 4Amidst More Bad News About HRT, Studies on Peruvian Maca Root Offer Hope to Women 2
(Date:8/29/2014)... 29, 2014 As reported by CNN.com in ... (8/15), the process of admitting that you need help for ... article acknowledges and highlights the fact that if you simply ... be very overwhelmed by all of the information that is ... to sift through, it is still possible to get help. ...
(Date:8/29/2014)... to new research presented in a Science Daily article entitled ... Misuse Among Young Adults (8/16), peer pressure should not ... comes to prescription drug abuse. Researchers from Purdue University have ... which influences misuse of prescription drugs is access to friends ... have fun with other using friends. Evidently there is not ...
(Date:8/29/2014)... August 29, 2014 An article entitled ... by Science Daily (8/18), explains how genes, gender and the ... woman’s likelihood of using drugs. Researchers at Indiana University are ... perceive the world differently, and are applying this factor to ... article argues that strong family and community ties can help ...
(Date:8/29/2014)... Formed in 2014, KAJ Brothers is a unique group ... Their sophisticated Pop/R&B sound, with beautiful orchestral elements is not ... experience every day. , The band has a ... with the primary purpose of elevating women with true love ... replied - “To make chivalry cool again, and help raise ...
(Date:8/29/2014)... Healthpointe has unveiled its new virtual ... of visiting with physicians online. Anyone can sign up ... doctors are always available and happy to see patients ... can even see the patient’s entire family. Once the ... can prescribe medications that are available for pick-up at ...
Breaking Medicine News(10 mins):Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 2Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2
... go through for those who suffer from it. Only those ... which emphasizes the importance of hope. It actually makes them ... is! It probably teaches one about living life to the ... even go to the extent of extending the enthusiasm for ...
... has tested the efficacy of a new combination therapy ... Prostate cancer patients who showed resistance to hormone ... II trial was conducted in 42 Prostate cancer patients ... Antigen (PSA) values. The results of the study were ...
... or no sunscreen in spite of staying under direct sunlight ... sports spend a significant amount of time practicing and competing ... they are spending so much time in the sun, they ... of them regularly use any form of sunscreen, according to ...
... colleagues in women with breast cancer has found that ... undergo Tamoxifen therapy compared to younger breast cancer patients ... the medical oncologist. The study published in the Journal ... with estrogen positive breast cancers, whereas younger patients receive ...
... knew no bounds when they got the news that Abu ... surgery to separate their conjoined twins.// ,'It is ... has offered to help us,' Khatoon, the mother of twins ... get medical attention at New Delhi's Apollo Hospital. ,Prince ...
... Leading biotech companies like Pfizer are increasingly interested ... are in the early phase 2 clinical trials.// ... then they used to be,” notes Roger Longman, ... Windhover information. The possibilities of going public after ...
Cached Medicine News:Health News:Some See A Hopeless End, While Others See An Endless Hope 2Health News:Combination Therapy To Avoid Prostate Cancer Recurrence 2Health News:People Still Neglect To Use Sunscreen In Spite Of Cancer Warnings 2Health News:When A Prince Chose To Help Indian Couple 2
... The Roche Diagnostics Task Targeted ... state-of-the-art automation of pre- ... laboratories: decapping, sorting / archiving ... into bar code labeled secondary ...
The Freedom EVO series platform offers a choice of flexible, scalable solutions for current and future application needs....
... a flexible liquid handling system that can ... liquid handlers all on the same worksurface. ... targeted applications or custom-tailored to meet your ... comprehensive systems that combine all the elements ...
... MSB is proud to offer the award winning ... known as the Dade DAC II automatic cell ... is a two-speed bench-top multi-purpose centrifuge primarily used ... The DAC II is truly a bench-top multipurpose ...
Medicine Products: